During the past decade, Showa University Fujigaoka Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Showa University Fujigaoka Hospital" #1 sponsor was "Bayer" with 3 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored, "Japan Clinical Cancer Research Organization" with 2 trials sponsored and "Japan Rhabdomyosarcoma Study Group" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Showa University Fujigaoka Hospital" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Korean Cancer Study Group" with 1 trials as a collaborator, "Taiho Pharmaceutical Co., Ltd." with 1 trials as a collaborator and "Tokyo Medical and Dental University" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Showa University Fujigaoka Hospital" are "Coronary Artery Disease" (4 trials), "Anemia" (3 trials), "Renal Insufficiency, Chronic" (3 trials), "Angina Pectoris" (2 trials) and "Gastric Cancer" (2 trials). Many other conditions were trialed in "Showa University Fujigaoka Hospital" in a lesser frequency.

Most popular intervention types in "Showa University Fujigaoka Hospital" are "Drug" (11 trials), "Device" (4 trials), "Biological" (2 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Molidustat (BAY85-3934)" (3 trials), "Darbepoetin alfa" (2 trials), "cyclophosphamide" (2 trials), "dactinomycin" (2 trials) and "vincristine sulfate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Showa University Fujigaoka Hospital" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Showa University Fujigaoka Hospital". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Showa University Fujigaoka Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Showa University Fujigaoka Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".